Genmab — Juli 2019
-
Den vil ryk-stige (skal vi sige 3-4%) både ved nye positive medd. om dara-sc og ofa-RMS. Desuden havde vi jo fx Horizon Pharmas Teprotumumab BLA-submission forleden.. til at understøtte kursen. Selvom det ikke giver meget skal man ikke lade sig narre af....... signalværdien!
-
Fra https://ir.genmab.com/news-releases/news-release-details/genmab-commences-public-offering-american-depositary-shares-adss :"It is expected that the ordinary shares underlying the ADSs will be admitted to trading and official listing on Nasdaq Copenhagen upon issuance." Så det er ganske almindelige GEN aktier - til handel i Kbh - der ligger nedenunder ADS'erne. Ift. diskussionen om shorterne kan/ikke kan dække ind.
-
Her står man kan https://www.investopedia.com/terms/a/ads.asp Der må være nogle banker der laver arbitrage på aktien ?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind